{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:25:50Z","timestamp":1791473150642,"version":"4.3.4"},"reference-count":239,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish Ministry of Education and Science for the Medical University of Gdansk","award":["01-10023\/256-0005008"],"award-info":[{"award-number":["01-10023\/256-0005008"]}]},{"name":"Medical University of Bialystok","award":["01-10023\/256-0005008"],"award-info":[{"award-number":["01-10023\/256-0005008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>The prevalence of neurodegenerative diseases (NDs) is increasing due to the aging population and improved longevity. They are characterized by a range of pathological hallmarks, including protein aggregation, mitochondrial dysfunction, and oxidative stress. The aim of this review is to summarize the alterations in brain energy and amino acid metabolism in Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and Huntington\u2019s disease (HD). Based on our findings, we proposed a group of selected metabolites related to disturbed energy or mitochondrial metabolism as potential indicators or predictors of disease. We also discussed the hidden challenges of metabolomics studies in NDs and proposed future directions in this field. We concluded that biochemical parameters of brain energy metabolism disruption (obtained with metabolomics) may have potential application as a diagnostic tool for the diagnosis, prediction, and monitoring of the effectiveness of therapies for NDs. However, more studies are needed to determine the sensitivity of the proposed candidates. We suggested that the most valuable biomarkers for NDs studies could be groups of metabolites combined with other neuroimaging or molecular techniques. To attain clinically applicable results, the integration of metabolomics with other \u201comic\u201d techniques might be required.<\/jats:p>","DOI":"10.3390\/metabo13030369","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T02:10:59Z","timestamp":1677723059000},"page":"369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy"],"prefix":"10.3390","volume":"13","author":[{"given":"Patrycja","family":"Maszka","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kwasniak-Butowska","sequence":"additional","affiliation":[{"name":"Division of Neurological and Psychiatric Nursing, Medical University of Gdansk, 80-211 Gdansk, Poland"},{"name":"Department of Neurology, St. Adalbert Hospital, 80-462 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0672","authenticated-orcid":false,"given":"Dominik","family":"Cysewski","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Slawek","sequence":"additional","affiliation":[{"name":"Division of Neurological and Psychiatric Nursing, Medical University of Gdansk, 80-211 Gdansk, Poland"},{"name":"Department of Neurology, St. Adalbert Hospital, 80-462 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-9414","authenticated-orcid":false,"given":"Ryszard T.","family":"Smolenski","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-9748","authenticated-orcid":false,"given":"Marta","family":"Tomczyk","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ruggiero, M., Calvello, R., Porro, C., Messina, G., Cianciulli, A., and Panaro, M.A. (2022). Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112958"},{"key":"ref_2","first-page":"a024091","article-title":"Cell Biology and Pathophysiology of \u03b1-Synuclein","volume":"8","author":"Sharma","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","article-title":"Intercellular Spread of Protein Aggregates in Neurodegenerative Disease","volume":"34","author":"Davis","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_4","first-page":"S3","article-title":"The Emerging Evidence of the Parkinson Pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.25122\/jml-2019-0088","article-title":"Possibilities of Dementia Prevention\u2014It is Never Too Early to Start","volume":"12","author":"Morovic","year":"2020","journal-title":"J. Med. Life"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.1174331","article-title":"Energy-Efficient Action Potentials in Hippocampal Mossy Fibers","volume":"325","author":"Alle","year":"2009","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000508054","article-title":"Brain Fuel Utilization in the Developing Brain","volume":"75","author":"Steiner","year":"2019","journal-title":"Ann. Nutr. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation","volume":"14","author":"Allaman","year":"2011","journal-title":"Cell Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1471-4159.2009.05941.x","article-title":"Direct measurement of oxidative metabolism in the living brain by microdialysis: A review","volume":"109","author":"Zielke","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tem.2022.03.001","article-title":"Metabolic changes favor the activity and heterogeneity of reactive astrocytes","volume":"33","author":"Xiong","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jcbfm.2009.197","article-title":"Altered Brain Mitochondrial Metabolism in Healthy Aging as Assessed by in vivo Magnetic Resonance Spectroscopy","volume":"30","author":"Boumezbeur","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lee, K.H., Cha, M., and Lee, B.H. (2021). Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413315"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13983","DOI":"10.1523\/JNEUROSCI.2040-10.2010","article-title":"The Contribution of Blood Lactate to Brain Energy Metabolism in Humans Measured by Dynamic 13C Nuclear Magnetic Resonance Spectroscopy","volume":"30","author":"Boumezbeur","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_14","first-page":"883","article-title":"Neurons rely on glucose rather than astrocytic lactate during stimulation","volume":"97","author":"Yellen","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ncb1881","article-title":"The Bioenergetic and Antioxidant Status of Neurons Is Controlled by Continuous Degradation of a Key Glycolytic Enzyme by APC\/C-Cdh1","volume":"11","author":"Almeida","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.niox.2022.11.006","article-title":"Nitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy","volume":"131","author":"Pappas","year":"2023","journal-title":"Nitric Oxide"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1073\/pnas.0831078100","article-title":"Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo","volume":"100","author":"Itoh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bittner, C.X., Loaiza, A., Ruminot, I., Larenas, V., Sotelo-Hitschfeld, T., Gutierrez, R., Cordova, A., Valdebenito, R., Frommer, W.B., and Barros, L.F. (2010). High resolution measurement of the glycolytic rate. Front. Neuroenerget., 2.","DOI":"10.3389\/fnene.2010.00026"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1523\/JNEUROSCI.0929-13.2013","article-title":"Calcium-Regulation of Mitochondrial Respiration Maintains ATP Homeostasis and Requires ARALAR\/AGC1-Malate Aspartate Shuttle in Intact Cortical Neurons","volume":"33","author":"Rueda","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/glia.20996","article-title":"Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons","volume":"58","author":"Halim","year":"2010","journal-title":"Glia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/jnr.21500","article-title":"Mitochondrial Transport Proteins of the Brain","volume":"85","author":"Berkich","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.arr.2016.02.003","article-title":"Brain fluorodeoxyglucose (FDG) PET in dementia","volume":"30","author":"Kato","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fphys.2020.00973","article-title":"Transport of Amino Acids Across the Blood-Brain Barrier","volume":"11","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched Chain Amino Acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Siddik, A.B., Mullins, C.A., Kramer, A., Shah, H., Gannaban, R.B., Zabet-Moghaddam, M., Huebinger, R.M., Hegde, V.K., MohanKumar, S.M.J., and MohanKumar, P.S. (2022). Branched-Chain Amino Acids Are Linked with Alzheimer\u2019s Disease-Related Pathology and Cognitive Deficits. Cells, 11.","DOI":"10.3390\/cells11213523"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnmol.2016.00053","article-title":"Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer\u2019s Disease","volume":"9","author":"Cunnane","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03168.x","article-title":"Monocarboxylate transporters in the central nervous system: Distribution, regulation and function","volume":"94","author":"Pierre","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11064-016-2099-2","article-title":"\u03b2-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms","volume":"42","author":"Achanta","year":"2016","journal-title":"Neurochem. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jensen, N., Wodschow, H., Nilsson, M., and Rungby, J. (2020). Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228767"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s12264-020-00587-3","article-title":"Dynamic Variations in Brain Glycogen are Involved in Modulating Isoflurane Anesthesia in Mice","volume":"36","author":"Fan","year":"2020","journal-title":"Neurosci. Bull."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.pneurobio.2021.102089","article-title":"Glucose metabolic crosstalk and regulation in brain function and diseases","volume":"204","author":"Zhang","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0271678X19856713","article-title":"How glycogen sustains brain function: A plausible allosteric signaling pathway mediated by glucose phosphates","volume":"39","author":"DiNuzzo","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Coggan, J.S., Keller, D., Cal\u00ec, C., Lehv\u00e4slaiho, H., Markram, H., Sch\u00fcrmann, F., and Magistretti, P.J. (2018). Norepinephrine stimulates glycogenolysis in astrocytes to fuel neurons with lactate. PLoS Comput. Biol., 14.","DOI":"10.1371\/journal.pcbi.1006392"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cmet.2021.05.003","article-title":"Brain glycogen serves as a critical glucosamine cache required for protein glycosylation","volume":"33","author":"Sun","year":"2021","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","article-title":"Autophagy in healthy aging and disease","volume":"1","author":"Aman","year":"2021","journal-title":"Nat. Aging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cca.2018.06.014","article-title":"Glycophagy: An emerging target in pathology","volume":"484","author":"Zhao","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1523\/JNEUROSCI.23-13-05928.2003","article-title":"Energy Contribution of Octanoate to Intact Rat Brain Metabolism Measured by 13C Nuclear Magnetic Resonance Spectroscopy","volume":"23","author":"Ebert","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2016.12.015","article-title":"Fats for thoughts: An update on brain fatty acid metabolism","volume":"84","author":"Romano","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tomczyk, M., Glaser, T., Slominska, E., Ulrich, H., and Smolenski, R. (2021). Purine Nucleotides Metabolism and Signaling in Huntington\u2019s Disease: Search for a Target for Novel Therapies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126545"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mochel, F., Charles, P., Seguin, F., Barritault, J., Coussieu, C., Perin, L., Le Bouc, Y., Gervais, C., Carcelain, G., and Vassault, A. (2007). Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000647"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11064-017-2261-5","article-title":"Branched-Chain Amino Acids and Brain Metabolism","volume":"42","author":"Sperringer","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/WNL.0b013e3181d3e44b","article-title":"Glycogen metabolism","volume":"74","author":"Benarroch","year":"2010","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"P1436","DOI":"10.1016\/j.jalz.2019.06.4029","article-title":"P4-358: Diagnostic value of the amnestic syndrome for alzheimer\u2019s disease: A clinicopathological study","volume":"15","author":"Bertoux","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100041","DOI":"10.1016\/j.bionps.2021.100041","article-title":"Diagnostic biomarkers in Alzheimer\u2019s disease","volume":"5","author":"Andersen","year":"2021","journal-title":"Biomark. Neuropsychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mroczek, M., Clark, C., Dayon, L., Bowman, G.L., and Popp, J. (2022). Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer\u2019s Disease. Cells, 11.","DOI":"10.3390\/cells11061030"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0404.1977.tb01420.x","article-title":"Long-term survival and predictors of mortality in Alzheimer\u2019s disease and multi-infarct dementia","volume":"91","author":"Marttila","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"114072","DOI":"10.1016\/j.socscimed.2021.114072","article-title":"The impact of long-term care service on total lifetime medical expenditure among older adults with dementia","volume":"280","author":"Moon","year":"2021","journal-title":"Soc. Sci. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12640-019-00116-9","article-title":"\u03b2-Amyloid Peptide: The Cell Compartment Multi-faceted Interaction in Alzheimer\u2019s Disease","volume":"37","author":"Picone","year":"2019","journal-title":"Neurotox. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1567205018666211208141017","article-title":"The Alzheimer\u2019s Disease Amyloid Precursor Protein and its Neuritogenic Actions","volume":"18","author":"Luu","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s43441-021-00373-x","article-title":"Application of 3D Whole-Brain Texture Analysis and the Feature Selection Method Based on within-Class Scatter in the Classification and Diagnosis of Alzheimer\u2019s Disease","volume":"56","author":"Zhou","year":"2022","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamem.2018.11.013","article-title":"The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer\u2019s disease","volume":"1861","author":"Tan","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00018-007-7220-x","article-title":"Tauopathies","volume":"64","author":"Avila","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e12996","DOI":"10.1111\/bpa.12996","article-title":"Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer\u2019s disease","volume":"31","author":"Ferrer","year":"2021","journal-title":"Brain Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/hbm.24782","article-title":"Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer\u2019s disease and mild cognitive impairment","volume":"40","author":"Chandra","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer\u2019s Disease","volume":"2","author":"Klosinski","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.clinthera.2021.05.006","article-title":"Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review","volume":"43","author":"Litke","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Mumtaz, S., Rana, J.N., Choi, E.H., and Han, I. (2022). Microwave Radiation and the Brain: Mechanisms, Current Status, and Future Prospects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169288"},{"key":"ref_65","first-page":"1","article-title":"Diagnosis of Early Alzheimer\u2019s Disease: Clinical Practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-170680","article-title":"Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer\u2019s Disease Diagnosis","volume":"62","author":"Bjerke","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2020). Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment. Molecules, 25.","DOI":"10.3390\/molecules25245789"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.yco.0000245747.53008.e2","article-title":"Seeing is believing: Neuroimaging adds to our understanding of cerebral pathology","volume":"19","author":"Small","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-210199","article-title":"Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer\u2019s Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study","volume":"82","author":"Duan","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12350-011-9490-9","article-title":"Advantages and disadvantages of PET and SPECT in a busy clinical practice","volume":"19","author":"Bateman","year":"2012","journal-title":"J. Nucl. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ricci, M., Cimini, A., Chiaravalloti, A., Filippi, L., and Schillaci, O. (2020). Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207481"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tem.2010.06.005","article-title":"Insulin signaling meets mitochondria in metabolism","volume":"21","author":"Cheng","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and Mitochondrial Cascades in Alzheimer\u2019s Disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/15216540601047767","article-title":"du Mitochondrial A\u03b2: A Potential Cause of Metabolic Dysfunction in Alzheimer\u2019s Disease","volume":"58","author":"Chen","year":"2006","journal-title":"IUBMB Life"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tang, J.X., Thompson, K., Taylor, R.W., and Ol\u00e1hov\u00e1, M. (2020). Mitochondrial OXPHOS Biogenesis: Co-Regulation of Protein Synthesis, Import, and Assembly Pathways. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113820"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ceca.2009.12.014","article-title":"The dysregulation of intracellular calcium in Alzheimer disease","volume":"47","author":"Supnet","year":"2010","journal-title":"Cell Calcium"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"13719","DOI":"10.1523\/JNEUROSCI.3006-07.2007","article-title":"The Cell-Selective Neurotoxicity of the Alzheimer\u2019s A\u03b2 Peptide Is Determined by Surface Phosphatidylserine and Cytosolic ATP Levels. Membrane Binding Is Required for A\u03b2 Toxicity","volume":"27","author":"Simakova","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Godoy, J., Rios, J., Pic\u00f3n-Pag\u00e8s, P., Herrera-Fern\u00e1ndez, V., Swaby, B., Crepin, G., Vicente, R., Fern\u00e1ndez-Fern\u00e1ndez, J., and Mu\u00f1oz, F. (2021). Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration. Biomolecules, 11.","DOI":"10.3390\/biom11071012"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer\u2019s disease: Role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"110841","DOI":"10.1016\/j.exger.2020.110841","article-title":"Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan","volume":"132","author":"Sutphin","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.bbapap.2016.06.014","article-title":"NAD + metabolism: Bioenergetics, signaling and manipulation for therapy","volume":"1864","author":"Yang","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"134576","DOI":"10.1016\/j.neulet.2019.134576","article-title":"Impaired metabolism of kynurenine and its metabolites in CSF of parkinson\u2019s disease","volume":"714","author":"Iwaoka","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5522981","DOI":"10.1155\/2021\/5522981","article-title":"Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer\u2019s Disease","volume":"2021","author":"Adeyemi","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer\u2019s disease: A biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/omi.2016.0106","article-title":"Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Amyotrophic Lateral Sclerosis","volume":"20","author":"Kori","year":"2016","journal-title":"OMICS J. Integr. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1038\/s41598-022-19670-y","article-title":"Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer\u2019s disease (from the Nakayama Study)","volume":"12","author":"Ozaki","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/acs.jproteome.5b01020","article-title":"Unbiased Metabolomic Investigation of Alzheimer\u2019s Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism","volume":"15","author":"Paglia","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/aje\/kwz116","article-title":"Association Between Serum \u03b2-Alanine and Risk of Dementia","volume":"188","author":"Hata","year":"2019","journal-title":"Am. J. Epidemiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12035-014-8672-2","article-title":"S-Nitrosylation in Alzheimer\u2019s disease","volume":"51","author":"Zhao","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_93","first-page":"91","article-title":"A Systematic Review on Urinary Biomarkers for Early Diagnosis of Alzheimer\u2019s Disease (AD)","volume":"10","author":"Rani","year":"2020","journal-title":"Int. J. Nutr. Pharmacol. Neurol. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/NEN.0000000000000116","article-title":"Lysophosphatidylcholine and Amide as Metabolites for Detecting Alzheimer Disease Using Ultrahigh-Performance Liquid ChromatographyYQuadrupole Time-of-Flight Mass Spectrometry-Based Metabonomics","volume":"73","author":"Cui","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/alz.12468","article-title":"Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s disease","volume":"18","author":"Horgusluoglu","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5665\/sleep.1838","article-title":"Diurnal Fluctuation in Histidine Decarboxylase Expression, the Rate Limiting Enzyme for Histamine Production, and Its Disorder in Neurodegenerative Diseases","volume":"35","author":"Shan","year":"2012","journal-title":"Sleep"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"198430","DOI":"10.4061\/2011\/198430","article-title":"Methionine-35 of A\u03b2(1\u201342): Importance for Oxidative Stress in Alzheimer Disease","volume":"2011","author":"Butterfield","year":"2011","journal-title":"J. Amino Acids"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","article-title":"Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer\u2019s disease: A prospective study in eight cohorts","volume":"14","author":"Tynkkynen","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease","volume":"107","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3233\/JAD-215448","article-title":"Targeted Metabolomic Analysis in Alzheimer\u2019s Disease Plasma and Brain Tissue in Non-Hispanic Whites","volume":"86","author":"German","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"Teav","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer\u2019s disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Rep."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Teixeira, J.P., de Castro, A.A., Soares, F.V., da Cunha, E.F.F., and Ramalho, T.C. (2019). Future Therapeutic Perspectives into the Alzheimer\u2019s Disease Targeting the Oxidative Stress Hypothesis. Molecules, 24.","DOI":"10.3390\/molecules24234410"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"104852","DOI":"10.1016\/j.livsci.2022.104852","article-title":"Application of an optimized and validated LC\u2013MS\/MS method for the quantification of free 3-nitrotyrosine in plasma, urine and liver tissue of lactating dairy cows","volume":"257","author":"Barcarolo","year":"2022","journal-title":"Livest. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-210497","article-title":"A Review of Oxidative Stress Products and Related Genes in Early Alzheimer\u2019s Disease","volume":"83","author":"Cioffi","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","article-title":"Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls","volume":"263","author":"Schwarcz","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Dalmasso, M.C., Ar\u00e1n, M., Galeano, P., Perin, S., Giavalisco, P., Adami, P.V.M., Novack, G.V., Casta\u00f1o, E.M., Cuello, A.C., and Scherer, M. (2023). Nicotinamide as potential biomarker for Alzheimer\u2019s disease: A translational study based on metabolomics. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.1067296"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.coph.2007.09.002","article-title":"Adenosine as a neuromodulator in neurological diseases","volume":"8","author":"Boison","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","article-title":"Cytochrome oxidase deficiency in Alzheimer\u2019s disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Janitschke, D., Lauer, A., Bachmann, C., Grimm, H., Hartmann, T., and Grimm, M. (2021). Methylxanthines and Neurodegenerative Diseases: An Update. Nutrients, 13.","DOI":"10.3390\/nu13030803"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-014-7331-x","article-title":"Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: A meta-analysis","volume":"261","author":"Abraham","year":"2014","journal-title":"J. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2567.2010.03283.x","article-title":"Regulation of Inflammasome Activity","volume":"130","author":"Guarda","year":"2010","journal-title":"Immunology"},{"key":"ref_114","first-page":"e12120","article-title":"LDL cholesterol and uridine levels in blood are potential nutritional biomarkers for clinical progression in Alzheimer\u2019s disease: The NUDAD project","volume":"12","author":"Tijms","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"904857","DOI":"10.3389\/fphar.2022.904857","article-title":"Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer\u2019s Disease","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s Disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s Disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural. Transm."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A Review of Parkinson\u2019s Disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson\u2019s Disease","volume":"9","author":"Nanni","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_121","first-page":"240","article-title":"Structure, function and toxicity of alpha-synuclein: The Bermuda triangle in synucleinopathies","volume":"139","author":"Outeiro","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/nature12126","article-title":"Bartels & Selkoe reply","volume":"498","author":"Bartels","year":"2013","journal-title":"Nature"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of \u03b1-synuclein in Parkinson\u2019s disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res."},{"key":"ref_124","unstructured":"Gowers, W. (2018). Parkinson\u2019s Disease Pathogenesis and Clinical Aspects, Codon Publications."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"134316","DOI":"10.1016\/j.neulet.2019.134316","article-title":"\u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies","volume":"709","author":"Henderson","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and Brain, Innate and Adaptive Immunity in Parkinson\u2019s Disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.1249547","article-title":"Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes","volume":"344","author":"Raj","year":"2014","journal-title":"Science"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.biocel.2011.06.002","article-title":"Ubiquitin-Dependent Mitochondrial Protein Degradation","volume":"43","author":"Heo","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Chen, C., Turnbull, D.M., and Reeve, A.K. (2019). Mitochondrial Dysfunction in Parkinson\u2019s Disease\u2014Cause or Consequence. Biology, 8.","DOI":"10.3390\/biology8020038"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Day, J., and Mullin, S. (2021). The Genetics of Parkinson\u2019s Disease and Implications for Clinical Practice. Genes, 12.","DOI":"10.3390\/genes12071006"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: A critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I Deficiency in Parkinson\u2019s Disease Frontal Cortex","volume":"1189","author":"Parks","year":"2008","journal-title":"Brain Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2009.11.065","article-title":"Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2\u2032-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson\u2019s disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process","volume":"469","author":"Isobe","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","article-title":"Exploring the Role of Ubiquitin\u2013Proteasome System in Parkinson\u2019s Disease","volume":"59","author":"Behl","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41386-018-0090-0","article-title":"Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease","volume":"44","author":"Holper","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2017.08.044","article-title":"Mitochondrial calcium imbalance in Parkinson\u2019s disease","volume":"663","author":"Ludtmann","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"100270","DOI":"10.1016\/j.ensci.2020.100270","article-title":"Kynurenine Pathway in Parkinson\u2019s Disease\u2014An Update","volume":"21","author":"Venkatesan","year":"2020","journal-title":"eNeurologicalSci"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","article-title":"The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson\u2019s Disease","volume":"23","author":"Ivanyuk","year":"2018","journal-title":"Cell Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab."},{"key":"ref_145","first-page":"195","article-title":"Iranian Journal of Neurology \u00a9 2015 Effects of L-Arginine Pre-Treatment in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson\u2019s Diseases in Balb\/c Mice","volume":"14","author":"Hosseini","year":"2015","journal-title":"Iran. J. Neurol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1423-0127-16-63","article-title":"Metabolic profiling of Parkinson\u2019s disease: Evidence of biomarker from gene expression analysis and rapid neural network detection","volume":"16","author":"Ahmed","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Gr\u00f6ger, A., Kolb, R., Sch\u00e4fer, R., and Klose, U. (2014). Dopamine Reduction in the Substantia Nigra of Parkinson\u2019s Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084081"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Recent Advances in Nutritional Sciences Glutathione Metabolism and Its Implications for Health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.14599","article-title":"The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson\u2019s disease","volume":"148","author":"Harrison","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Lukasheva, E., Makletsova, M., Lukashev, A., Babayeva, G., Arinbasarova, A., and Medentsev, A. (2020). Fungal Enzyme l-Lysine \u03b1-Oxidase Affects the Amino Acid Metabolism in the Brain and Decreases the Polyamine Level. Pharmaceuticals, 13.","DOI":"10.3390\/ph13110398"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural. Transm."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s11011-022-01004-6","article-title":"Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson\u2019s Disease","volume":"37","author":"Yan","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnagi.2018.00051","article-title":"Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson\u2019s Disease","volume":"10","author":"Stoessel","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","article-title":"The concept of alpha-synuclein as a prion-like protein: Ten years after","volume":"373","author":"Steiner","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1007\/s12035-017-0845-3","article-title":"Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson\u2019s Disease","volume":"55","author":"Chang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.14104","article-title":"Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia","volume":"142","author":"Havelund","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13578-022-00831-5","article-title":"Metabolomics of blood reveals age-dependent pathways in Parkinson\u2019s Disease","volume":"12","author":"Antonecchia","year":"2022","journal-title":"Cell Biosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","article-title":"Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target","volume":"10","author":"Sorgdrager","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","article-title":"Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry","volume":"16","author":"Shao","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"136428","DOI":"10.1016\/j.neulet.2021.136428","article-title":"Analysis of circulating metabolites to differentiate Parkinson\u2019s disease and essential tremor","volume":"769","author":"Ostrakhovitch","year":"2022","journal-title":"Neurosci. Lett."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FPC.0b013e32835693f7","article-title":"Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson\u2019s disease","volume":"22","author":"Kurzawski","year":"2012","journal-title":"Pharm. Genom."},{"key":"ref_162","first-page":"1","article-title":"The Impact of MRI White Matter Hyperintensities on Dementia in Parkinson\u2019s Disease in Relation to the Homocysteine Level and Other Vascular Risk Factors","volume":"12","author":"Roszmann","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2016.09.061","article-title":"Polyneuropathy in levodopa-treated Parkinson\u2019s patients","volume":"371","author":"Szadejko","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/acn3.51227","article-title":"Role of homocysteine in the development and progression of Parkinson\u2019s disease","volume":"7","author":"Fan","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0753-3322(02)00285-8","article-title":"II. Glutamine and Glutamate","volume":"56","author":"Tapiero","year":"2002","journal-title":"Biomed. Pharmacother."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Kwon, E.H., Tennagels, S., Gold, R., Gerwert, K., Beyer, L., and T\u00f6nges, L. (2022). Update on CSF Biomarkers in Parkinson\u2019s Disease. Biomolecules, 12.","DOI":"10.3390\/biom12020329"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Willkommen, D., Lucio, M., Moritz, F., Forcisi, S., Kanawati, B., Smirnov, K.S., Schroeter, M., Sigaroudi, A., Schmitt-Kopplin, P., and Michalke, B. (2018). Metabolomic investigations in cerebrospinal fluid of Parkinson\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208752"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"G\u0105tarek, P., Sekulska-Nalewajko, J., Bobrowska-Korczaka, B., Pawe\u0142czyk, M., Jastrz\u0119bski, K., G\u0142\u0105bi\u0144ski, A., and Ka\u0142u\u017cna-Czapli\u0144ska, J. (2022). Plasma Metabolic Disturbances in Parkinson\u2019s Disease Patients. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123005"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2021.03.009","article-title":"Biosensors in Parkinson\u2019s disease","volume":"518","author":"Mobed","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clineuro.2009.06.012","article-title":"Serum uric acid levels in patients with Parkinson\u2019s disease: Their relationship to treatment and disease duration","volume":"111","author":"Andreadou","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/mds.29209","article-title":"Uric Acid in Parkinson\u2032s Disease: What Is the Connection","volume":"37","author":"Seifar","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2174\/1386207323666200428082815","article-title":"GC-MS Based Metabolic Profiling of Parkinson\u2019s Disease with Glutathione S-transferase M1 and T1 Polymorphism in Tunisian Patients","volume":"23","author":"Rebai","year":"2020","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_174","first-page":"501","article-title":"Parkinson\u2019s Disease in Women and Men: What\u2019s the Difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Park. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","article-title":"Huntington Disease","volume":"33","author":"Dayalu","year":"2015","journal-title":"Neurol. Clin."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-12-801893-4.00005-5","article-title":"The diagnosis and natural history of Huntington disease","volume":"144","author":"Pagan","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington\u2019s Disease","volume":"11","author":"Frank","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/mdc3.13148","article-title":"Disease Onset in Huntington\u2019s Disease: When Is the Conversion","volume":"8","author":"Oosterloo","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","article-title":"HD CAG-correlated gene expression changes support a simple dominant gain of function","volume":"20","author":"Jacobsen","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1600-0854.2008.00701.x","article-title":"The Itinerary of Autophagosomes: From Peripheral Formation to Kiss-and-Run Fusion with Lysosomes","volume":"9","author":"Jahreiss","year":"2008","journal-title":"Traffic"},{"key":"ref_183","first-page":"1068","article-title":"Molecular Strategies to Target Protein Aggregation in Huntington\u2019s Disease","volume":"8","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease","volume":"13","author":"Talloczy","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1038\/cddis.2009.6","article-title":"Mutant Huntingtin induces activation of the Bcl-2\/adenovirus E1B 19-kDa interacting protein (BNip3)","volume":"1","author":"Sassone","year":"2010","journal-title":"Cell Death Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","article-title":"Huntington\u2019s disease: Diagnosis and management","volume":"22","author":"Stoker","year":"2021","journal-title":"Pract. Neurol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/nmt-2018-0040","article-title":"Deutetrabenazine in the treatment of Huntington\u2019s disease","volume":"9","author":"Richard","year":"2019","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/mds.25992","article-title":"Metabolism in HD: Still a Relevant Mechanism?","volume":"29","author":"Duan","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","article-title":"Striatal synaptic dysfunction and altered calcium regulation in Huntington disease","volume":"483","author":"Raymond","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbrc.2006.01.136","article-title":"Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction","volume":"342","author":"Goswami","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.2010.05629.x","article-title":"Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1","volume":"1201","author":"Chang","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-Activated Protein Kinase Signaling in Metabolic Regulation","volume":"116","author":"Yun","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12640-019-9997-4","article-title":"Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms","volume":"35","author":"Jacobs","year":"2019","journal-title":"Neurotox. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","article-title":"Development of Biomarkers for Huntington\u2019s Disease","volume":"10","author":"Leavitt","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bbadis.2016.06.002","article-title":"Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington\u2019s disease human brain","volume":"1862","author":"Patassini","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_197","first-page":"4","article-title":"Huntington\u2019 Disease-Imbalance of Amino Acid Levels in Plasma of Patients and Mutation Carriers","volume":"20","author":"Gruber","year":"2013","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mds.23974","article-title":"Serum levels of N-acetylaspartate in Huntington\u2019s disease: Preliminary results","volume":"27","author":"Ruggieri","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"dmm049492","DOI":"10.1242\/dmm.049492","article-title":"Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation","volume":"15","author":"Pradhan","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic Characterization of the R6\/2 Transgenic Mouse Model of Huntington\u2019s Disease by High-Resolution MAS 1H NMR Spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0404.1995.tb00438.x","article-title":"Decreased plasma alanine and isoleucine in Huntington\u2019s disease","volume":"91","author":"Reilmann","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Szejko, N. (2022). From Pathophysiology to Treatment of Huntington\u2019s Disease, IntechOpen.","DOI":"10.5772\/intechopen.94806"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.irn.2015.05.006","article-title":"Metabolomics of Neurodegenerative Diseases","volume":"122","author":"Botas","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11306-016-1084-8","article-title":"Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington\u2019s disease peripheral blood samples","volume":"12","author":"Mastrokolias","year":"2016","journal-title":"Metabolomics"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors","volume":"46","author":"Futter","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Christodoulou, C.C., Zachariou, M., Tomazou, M., Karatzas, E., Demetriou, C.A., Zamba-Papanicolaou, E., and Spyrou, G.M. (2020). Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington\u2019s Disease Status Based on Omics Data. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197414"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14728222.2019.1549231","article-title":"Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington\u2019s disease","volume":"23","author":"Boros","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Przybyl, L., Wozna-Wysocka, M., Kozlowska, E., and Fiszer, A. (2021). What, When and How to Measure\u2014Peripheral Biomarkers in Therapy of Huntington\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041561"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","article-title":"Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington\u2019s disease","volume":"112","author":"Forrest","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"20490","DOI":"10.1038\/s41598-020-77526-9","article-title":"Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington\u2019s disease for participants of varying functional disability: A pilot study","volume":"10","author":"McGarry","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1089\/ars.2017.7145","article-title":"Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration","volume":"28","author":"Pehar","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11302-006-9038-7","article-title":"Extracellular NAD and ATP: Partners in immune cell modulation","volume":"3","author":"Haag","year":"2007","journal-title":"Purinergic Signal."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.bbadis.2016.08.019","article-title":"An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington\u2019s disease related cardiomyopathy","volume":"1862","author":"Toczek","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1021\/acs.jproteome.6b00049","article-title":"Novel Metabolite Biomarkers of Huntington\u2019s Disease As Detected by High-Resolution Mass Spectrometry","volume":"15","author":"Graham","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/acn3.214","article-title":"A systems-level \u201cmisunderstanding\u201d: The plasma metabolome in Huntington\u2019s disease","volume":"2","author":"Rosas","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Tomczyk, M., Braczko, A., Mierzejewska, P., Podlacha, M., Krol, O., Jablonska, P., Jedrzejewska, A., Pierzynowska, K., Wegrzyn, G., and Slominska, E.M. (2022). Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington\u2019s Disease. Cells, 11.","DOI":"10.3390\/cells11172662"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JHD-170273","article-title":"A Critical Evaluation of Wet Biomarkers for Huntington\u2019s Disease: Current Status and Ways Forward","volume":"7","year":"2018","journal-title":"J. Huntington\u2019s Dis."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21037\/jlpm.2018.11.01","article-title":"Detection of 8-OHdG as a diagnostic biomarker","volume":"3","author":"Korkmaz","year":"2018","journal-title":"J. Lab. Precis. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"32581","DOI":"10.1038\/srep32581","article-title":"Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2\u2032-deoxyguanosine by UPLC-MS\/MS Analysis","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00125-017-4510-1","article-title":"Plasma concentrations of 8-hydroxy-2\u2032-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes","volume":"61","author":"Sanchez","year":"2017","journal-title":"Diabetologia"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/ars.2015.6508","article-title":"8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease: A Systematic Review and Meta-Analysis of the Literature","volume":"24","author":"Turnu","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Hakoda, M., and Ichida, K. (2022). Genetic Basis of the Epidemiological Features and Clinical Significance of Renal Hypouricemia. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071696"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0272-6386(98)70067-8","article-title":"Regulation of renal urate excretion: A critical review","volume":"32","author":"Maesaka","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_228","first-page":"E567","article-title":"Effects of protein restriction and acute refeeding on leucine and lysine kinetics in young men","volume":"264","author":"Hoerr","year":"1993","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"S2548","DOI":"10.1093\/jn\/nxaa224","article-title":"Review of Lysine Metabolism with a Focus on Humans","volume":"150","author":"Matthews","year":"2020","journal-title":"J. Nutr."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1471-4159.1988.tb02983.x","article-title":"Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer\u2019s Disease","volume":"50","author":"Procter","year":"1988","journal-title":"J. Neurochem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41531-022-00312-z","article-title":"Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson\u2019s disease","volume":"8","author":"Zhang","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"792711","DOI":"10.3389\/fimmu.2021.792711","article-title":"Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"bvac061","DOI":"10.1210\/jendso\/bvac061","article-title":"Metabolomic Profiling of Peripheral Plasma by GC-MS and Correlation with Size of Uterine Leiomyomas","volume":"6","author":"Barison","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Baranyi, A., Amouzadeh-Ghadikolai, O., Von Lewinski, D., Rothenh\u00e4usler, H.-B., Theokas, S., Robier, C., Mangge, H., Reicht, G., Hlade, P., and Meinitzer, A. (2016). Branched-Chain Amino Acids as New Biomarkers of Major Depression \u2014A Novel Neurobiology of Mood Disorder. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160542"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jnc.15360","article-title":"Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington\u2019s disease","volume":"158","author":"Rodrigues","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.48.5.469","article-title":"Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer\u2019s dementia","volume":"48","author":"Smith","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fpsyt.2018.00561","article-title":"Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients with Probable Alzheimer\u2019s Disease and Depression","volume":"9","author":"Madeira","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"648740","DOI":"10.1155\/2014\/648740","article-title":"Shared Mechanisms of Neurodegeneration in Alzheimer\u2019s Disease and Parkinson\u2019s Disease","volume":"2014","author":"Xie","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00401-017-1722-x","article-title":"Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins","volume":"134","author":"Flavin","year":"2017","journal-title":"Acta Neuropathol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/3\/369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:28Z","timestamp":1760121928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/13\/3\/369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":239,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["metabo13030369"],"URL":"https:\/\/doi.org\/10.3390\/metabo13030369","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}